Skip to content
Multidisciplinary Association for Psychedelic Studies – MAPS

Multidisciplinary Association for Psychedelic Studies - MAPS

  • About
    • Our Mission
    • Our History
    • Our Team
    • Community Allies
  • Our Work
    • Advancing Research
    • Changing Policy
    • Evolving Education
    • The Virtual Trip
  • News
    • Updates
    • Newsletter
    • Press Releases
    • MAPS Bulletin
    • MAPS in the Media
    • Newsroom
  • Take Action
    • MAPS Membership
    • Donate
    • Volunteer
    • Careers
    • Community Events
    • Resources
    • Integration Station
    • Music Is the Bridge
  • Store
    • The Dose (New Items)
    • Learning
    • Apparel
    • Accessories
    • Bookshop
Login
  • Donate
0

MDMA-Assisted Therapy

Bergman Leads 60 Members in Letter to Highlight New Groundbreaking Therapy, Stop Veteran Suicide

August 5, 2024

Making Sense with Sam Harris: The Future of Psychedelic Medicine 2

July 28, 2024

The Unbelievable Claims of Psymposia about MAPS and MDMA-Assisted Therapy | Chacruna

July 19, 2024

Experts Endorse MDMA-assisted Therapy for PTSD

July 7, 2024

MAPS Remains Hopeful, Awaits FDA Decision on MDMA-Assisted Therapy for PTSD

Dear Friends and Allies, On June 4, 2024, the U.S. Food and Drug Administration (FDA) convened a meeting of the Psychopharmacologic Drugs Advisory Committee to evaluate Lykos Therapeutics’ (Lykos) New …
June 17, 2024

The State Committee of the Netherlands on MDMA: Report presentation by Wim van den Brink

View the report here.
June 13, 2024

MDMA /// Beyond Ecstasy | Report from the Dutch State Commission

May 31, 2024

Lykos Therapeutics Announces Completion of European Phase 2 Study for MDMA-Assisted Therapy for PTSD

April 24, 2024

Why does MDMA work for PTSD? A new study yields clues about psychedelics and trauma therapy | Vox

January 29, 2024

MAPS Celebrates Submission of New Drug Application to FDA for MDMA-Assisted Therapy for PTSD

FOR IMMEDIATE RELEASE: December 13, 2023 MAPS Public Benefit Corporation (MAPS PBC) formally submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) which included data from …
December 13, 2023

MAPS PBC Publishes Results of Successful Confirmatory Phase 3 Trial of MDMA-Assisted Therapy for PTSD

FOR IMMEDIATE RELEASE: September 14, 2023 Results of the second, confirmatory Phase 3 trial of MDMA-assisted therapy for posttraumatic stress disorder, MAPP2, have been published in Nature Medicine. MAPP2 …
September 13, 2023

ECOA: Lieutenant uses psychedelics to combat police violence in the US.

It was at an IACP conference in Florida, the largest event for police officers in the world, that Gergerian met Rick Doblin, the former hippie and founder of Maps (an acronym in English for “Multidisciplinary …
June 4, 2023

Posts pagination

Newer Posts Page 1 Page 2 … Page 31 Older Posts
Multidisciplinary Association for Psychedelic Studies – MAPS
  • About
    • Our Mission
    • Our History
    • Our Team
    • Financial Reports
    • Careers
    • Refunds & Returns
    • FAQs
    • Privacy Policy
    • Global Affiliates
  • Our Work
    • Psychedelic Fundamentals
    • The Virtual Trip
    • U.S. MDMA Therapy Education
    • Health Equity
    • Policy & Advocacy
  • Advancing Research
    • MDMA
    • Marijuana
    • LSD
    • Ibogaine
    • Ayahuasca
  • News
    • Updates
    • MAPS in the Media
    • MAPS Bulletin
    • MAPS Podcast
    • Monthly Newsletter
    • Press Releases
    • Newsroom
  • Take Action
    • MAPS Membership
    • Donate
    • Participate in a Trial
    • Events
    • Resources

Newsletter Sign Up

  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn
  • Reddit
© 1986 - 2026 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved. Disclaimer | Privacy Policy.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mail checks to: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.
Designed with WordPress. Hosted by Pressable.

Download our Integration Guide

Just enter your email in order to download our Integration Guide